Determine the necessary mass, volume, or concentration for preparing a solution.
•Protein-protein interactions (PPI) represent a vast class of therapeutic targets both inside and outside the cell.Inhibitors of a number of protein–protein interactions (PPIs) have emerged as potential anticancer drug candidates;
•A unique collection of 173 protein-protein Interaction(PPI) Inhibitors used for high throughput screening(HTS) and high content screening(HCS);
•Targets PD-1/PD-L1, BCL family, Bromodomains, MDM2, HIV integrase, etc.
•Some compounds have been approved by the FDA;
•Structurally diverse,medicinally active,and cell permeable;
•Rich documentation with structure and bioactivity information;
•NMR and HPLC validated to ensure high purity.
Product Details
| |||||||||||||||||||